HIGHLIGHTS
- who: Seu00e7kin Akgu00fcl from the School of Medicine and Dentistry, Griffith University, Gold Coast , QLD, Australia have published the Article: Carboplatin dose calculations for patients with lung cancer: significant dose differences found depending on dosing equation choice, in the Journal: (JOURNAL)
- what: The authors demonstrate potential real-world benefit as predicted lower doses for patients whose (CG-derived) dose was later reduced following clinical assessment prior to infusion. The authors aimed to determine how the CG-based carboplatin dosages would have changed if MDRD- or CKD-EPIbased eGFR values were applied in the Calvert formula . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.